Dahai Wang
16Patents
1h-index
53Co-inventors
53Inventor score
Filing activity: Feb 24, 2005 → Jun 26, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7107828B2 | Method and code for controlling actuator responsive to oil pressure using oil viscosity measure | Physics | 4 | Expired |
| US10246457B2 | Indazole and azaindazole Btk inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10787441B2 | Hepatitis C virus inhibitors | Human Necessities | 0 | Active |
| US11236107B2 | Crystal of tricyclic compound | Chemistry; Metallurgy | 0 | Active |
| US10087188B2 | Benzamide imidazopyrazine Btk inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10208047B2 | Tertiary alcohol imidazopyrazine BTK inhibitors | Human Necessities | 0 | Active |
| US10646494B2 | Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases | Chemistry; Metallurgy | 0 | Active |
| US9828365B2 | Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseases | Chemistry; Metallurgy | 0 | Active |
| US10487088B2 | Tricyclic compound serving as immunomodulator | Emerging Cross-Sectional Technologies | 0 | Active |
| US11511780B2 | Carriage, head carriage, middle carriage, and train | Performing Operations; Transporting | 0 | Active |
| US8717195B2 | Traffic signal control system, design method and special equipment | Physics | 0 | Active |
| US11407717B2 | Benzimidazole derivatives and use thereof as IDH1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10214546B2 | Btk inhibitors | Human Necessities | 0 | Active |
| US9504690B2 | Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases | Chemistry; Metallurgy | 0 | Active |
| US10738062B2 | Chromane-substituted tetracyclic compounds and uses thereof for the treatment of viral diseases | Human Necessities | 0 | Active |
| US10040805B2 | Substituted imidazo[1,5-a]pyrazines as Btk inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.